Prescription Drug Marketing Investment- Chapter II Section I break a prerequisite for successful pharmaceutical enterprises investment.docVIP

 PAGE \* MERGEFORMAT 17 Prescription Drug Marketing Investment: Chapter II Section I break a prerequisite for successful pharmaceutical enterprises investment Adapted from the book, Cheng Zhao: lt;lt;Prescription Drug Marketing Investmentgt;gt; ISBN :978-7-5017-9933-6 / C #8226; 70 Of: Zhao Zheng Price: 32.00 yuan Folio: 16 open Version: China Economic Press Publication Date: August 2010 published Added suggestions: Marketing Chapter pharmaceutical investment under the new situation, focusing on the “Road” For the pharmaceutical industry in 2009 is destined to be a landmark year. Since the beginning in June 2009, 21 medical reform sign after the partial introduction of supporting documents, when the announcement effect of a number of pharmaceutical policy from 2010 began to appear, the key supporting policies, programs also will appear .2010 intensive pharmaceutical industry in China has therefore become a new beginning, and some even predicted that the next 10 years the pharmaceutical industry will become the golden period of development. Pharmaceutical industry in 2010 will continue a series of mergers and acquisitions in 2009 of the wind, 2009, occurred the case of some big mergers and acquisitions, and new medical reform brought about industry consolidation in 2010 will have a tremendous impact on the pharmaceutical industry. For example drugs introduced in 2010 for the first time centralized purchasing and distribution, pharmaceutical business in 2010 will accelerate the integration. at all levels of medical institutions in the implementation of centralized procurement and distribution of pharmaceutical tender, on the distributors of information management, logistics capabilities of hardware and software requirements greatly increased the threshold, the SME will inevitably be large-scale acquisition of modern business enterprise. From the Beijing Drug Administration lt;”On the medical institutions in Beijing in 2009 to carry out cent